Biocatalytic Routes to Enantiomerically Enriched Dibenz[c,e]azepines
Biocatalytic Routes to Enantiomerically Enriched Dibenz[c,e]azepines
复制标题
DOI:
10.1002/anie.201708453
复制
发表时间:
2017-12-04
影响因子:
16.6
通讯作者:
Turner, Nicholas J.
中科院分区:
文献类型:
--
作者:
France, Scott P.;Aleku, Godwin A.;Turner, Nicholas J.
Biocatalytic retrosynthetic analysis of dibenz[c,e]azepines has highlighted the use of imine reductase (IRED) and omega-transaminase (omega-TA) biocatalysts to establish the key stereocentres of these molecules. Several enantiocomplementary IREDs were identified for the synthesis of (R)- and (S)-5-methyl-6,7-dihydro-5H-dibenz[c,e]azepine with excellent enantioselectivity, by reduction of the parent imines. Crystallographic evidence suggests that IREDs may be able to bind one conformer of the imine substrate such that, upon reduction, the major product conformer is generated directly. omega-TA biocatalysts were also successfully employed for the production of enantiopure 1-(2-bromophenyl)ethan-1-amine, thus enabling an orthogonal route for the installation of chirality into dibenz[c,e]azepine framework.